Trichomoniasis other diagnostic studies: Difference between revisions

Sexually transmitted diseases Main Page
Vaginitis Main Page
	Trichomoniasis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Trichomoniasis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Trichomoniasis other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Trichomoniasis other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Trichomoniasis other diagnostic studies
CDC on Trichomoniasis other diagnostic studies
Trichomoniasis other diagnostic studies in the news
Blogs on Trichomoniasis other diagnostic studies
Directions to Hospitals Treating Trichomoniasis
Risk calculators and risk factors for Trichomoniasis other diagnostic studies

Revision as of 20:17, 5 February 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 3: / Line 3: @@
 {{CMG}}
-==Other Diagnostic Studies==
-FDA-cleared tests for trichomoniasis in women include OSOM Trichomonas Rapid Test (Genzyme Diagnostics, Cambridge, Massachusetts), an immunochromatographic capillary flow dipstick technology, and the Affirm™ VP III (Becton Dickenson, San Jose, California), a [[nucleic acid]] probe test that evaluates for T. vaginalis, G. vaginalis, and C. albicans. These tests are both performed on vaginal secretions and have a [[sensitivity]] >83% and a [[specificity]] >97%. Both tests are point-of-care diagnostics. The results of the OSOM Trichomonas Rapid Test are available in approximately 10 minutes, and results of the Affirm™ VP III are available within 45 minutes. Although these tests tend to be more sensitive than vaginal wet preparation, [[false positive]]s might occur especially in low [[prevalence]] populations. Culture is the most sensitive and specific commercially available method of diagnosis. In women in whom trichomoniasis is suspected but not confirmed by [[microscopy]], vaginal secretions should be cultured for T. vaginalis.
 ==References==